S. Aquilonius

发表

Topographical localization of motor endplates in cryosections of whole human muscles

Håkan Askmark, Yngve Olsson, Y. Olsson, 1984, Muscle & nerve.

Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease

D. Nyholm, S. Aquilonius, H. Askmark, 2005, Neurology.

Levodopa/carbidopa microtablets in Parkinson’s disease: a study of pharmacokinetics and blinded motor assessment

J. Westin, D. Nyholm, Mevludin Memedi, 2017, European Journal of Clinical Pharmacology.

Wireless real‐time electronic data capture for self‐assessment of motor function and quality of life in Parkinson's disease

D. Nyholm, S. Aquilonius, J. Kowalski, 2004, Movement disorders : official journal of the Movement Disorder Society.

Development of new levodopa treatment strategies in Parkinson’s disease—from bedside to bench to bedside

D. Nyholm, S. Aquilonius, 2017, Upsala journal of medical sciences.

What has PET told us about Parkinson's disease?

S. Aquilonius, 1991, Acta neurologica Scandinavica. Supplementum.

Magnetic resonance imaging of the brain in Wilson's disease

K. Bergström, K. Thuomas, S. Aquilonius, 2004, Neuroradiology.

Pharmacokinetics of Levodopa/Carbidopa Microtablets Versus Levodopa/Benserazide and Levodopa/Carbidopa in Healthy Volunteers

T. Lewander, D. Nyholm, S. Aquilonius, 2012, Clinical neuropharmacology.

Frequent administration of levodopa/carbidopa microtablets vs levodopa/carbidopa/entacapone in healthy volunteers

T. Lewander, D. Nyholm, S. Aquilonius, 2013, Acta neurologica Scandinavica.

Computerised tomography in severe methanol intoxication.

S. Aquilonius, H. Askmark, U. Moström, 1978, British medical journal.

Estimation of regional cerebral utilization of [11C]‐L‐3, 4‐dihydroxy‐phenylalanine (DOPA) in the primate by positron emission tomography

B. Långström, P. Hartvig, H. Lundqvist, 1992, Acta neurologica Scandinavica.

CNS distribution of cholinergic receptors--some questions from a clinical neuroscientist.

S. Aquilonius, 1993, Progress in brain research.

In vivo turnover rate of acetylcholine in rat brain parts at elevated steady-state concentration of plasma choline.

S. Aquilonius, S. Eckernäs, L. Sahlström, 1977, Acta physiologica Scandinavica.

Choline acetyltransferase and substance P-like immuno-reactivity in the human spinal cord: changes in amyotrophic lateral sclerosis

B. Winblad, S. Aquilonius, P. Gillberg, 1982, Brain Research.

Monoamine re‐uptake sites in the human brain evaluated in vivo by means of 11C‐nomifensine and positron emission tomography: the effects of age and Parkinson's disease

H Lundqvist, B. Långström, P. Hartvig, 1988, Acta neurologica Scandinavica.

Regional distribution of choline acetyltransferase in the human brain: changes in Huntington's chorea.

S. Aquilonius, A. Sundwall, S. Eckernås, 1975, Journal of neurology, neurosurgery, and psychiatry.

Positron emission tomography (PET) in the study of dopamine receptors in the primate brain: evaluation of a kinetic model using 11C‐N‐methyl‐spiperone

K. Någren, P. Hartvig, H. Lundqvist, 1987, Acta neurologica Scandinavica.

An automatic dose dispenser for microtablets--a new concept for individual dosage of drugs in tablet form.

D. Nyholm, S. Aquilonius, S. Bredenberg, 2003, International journal of pharmaceutics.

A Swedish county with unexpectedly high utilization of anti‐Parkinsonian drugs

P. Hartvig, S. Aquilonius, 1986, Acta Neurologica Scandinavica.

Cholinesterase inhibitors lack therapeutic effect in amyotrophic lateral sclerosis. A controlled study of physostigmine versus neostigmine

E. Stålberg, S. Aquilonius, H. Askmark, 1986, Acta neurologica Scandinavica.

Muscle spindle activity in alternating tremor of Parkinsonism and in clonus.

K. Hagbarth, G. Wallin, L. Löfstedt, 1975, Journal of neurology, neurosurgery, and psychiatry.

POSITRON EMISSION TOMOGRAPHY IN CHOLINERGIC NEUROPHARMACOLOGY

T. Greitz, B. Berggren, M. Bergström, 1981 .

Neuropharmacology of amyotrophic lateral sclerosis.

S. Aquilonius, H. Askmark, P. Gillberg, 1990, Progress in brain research.

MEASUREMENT OF RIGIDITY AND TREMOR IN PARKINSON'S DISEASE

S. Aquilonius, P. Tiselius, 1969, Acta neurologica Scandinavica.

Poor hydroxylator phenotypes of debrisoquine and S-mephenytoin are not over-represented in a group of patients with Parkinson's disease.

S. Aquilonius, J. Reviriego, G. Alván, 1990, British journal of clinical pharmacology.

Choline therapy in Huntington chorea

S. Aquilonius, S. Eckernâs, 1977, Neurology.

Cerebrospinal fluid choline in extrapyramidal disorders1

S. Aquilonius, B. Nyström, J. Schuberth, 1972, Journal of neurology, neurosurgery, and psychiatry.

mRNA expression of neurotrophins and members of the trk family in the rat brain after treatment with L‐deprenyl

S. Aquilonius, L. Oreland, S. Söderström, 1994, Acta neurologica Scandinavica.

Distribution of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in experimental animals studied by postiron emission tomography and whole body autoradiography.

K. Bergström, P. Hartvig, S. Aquilonius, 1986, Life sciences.

Autoradiographic changes of 3H-alpha-bungarotoxin binding in rat hind limb muscles after a cryoinjury of the sciatic nerve and in acrylamide intoxication.

S. Aquilonius, H. Askmark, A. Liljeborg, 1985, Acta physiologica Scandinavica.

Autoradiographic visualization of extrajunctional acetylcholine receptors in whole human biceps brachii muscle Changes in amyotrophic lateral sclerosis

S. Aquilonius, H. Askmark, P. Gillberg, 1985, Acta neurologica Scandinavica.

In vitro autoradiographic studies of 3H-alpha-bungarotoxin and 3H-quinuclidinylbenzilate binding in rat hind limb muscles.

S. Aquilonius, H. Askmark, A. Liljeborg, 1984, Acta physiologica Scandinavica.

Screening for neurotrophic disturbances in amyotrophic lateral sclerosis

S. Aquilonius, H. Askmark, T. Ebendal, 1989, Acta neurologica Scandinavica.

Reactive gliosis and monoamine oxidase B.

S. Aquilonius, E. Walum, L. Oreland, 1994, Journal of neural transmission. Supplementum.

Amyotrophic Lateral Sclerosis

S. Aquilonius, H. Askmark, 1994 .

Amyotrophic lateral sclerosis: evidence for intact hepatocyte growth factor/met signalling axis.

P. Schirmacher, A. Wallin, S. Aquilonius, 2001, Cytokine.

High 3H‐vesamicol binding in ALS motor neurons – autoradiographic visualization of hyperactivity?

S. Aquilonius, P. Gillberg, E. Grundström, 2001, Acta neurologica Scandinavica.

Methionine Adenosyltransferase Activity in Erythrocytes and Spinal Cord of Patients with Sporadic Amyotrophic Lateral Sclerosis

S. Aquilonius, H. Askmark, C. Gomes-Trolin, 1999, Experimental Neurology.

Increased expression of glial cell line-derived neurotrophic factor mRNA in muscle biopsies from patients with amyotrophic lateral sclerosis

S. Aquilonius, H. Askmark, I. Nygren, 1999, Journal of the Neurological Sciences.

A pilot trial of dextromethorphan in amyotrophic lateral sclerosis.

E. Stålberg, S. Aquilonius, H. Askmark, 1993, Journal of neurology, neurosurgery, and psychiatry.

Focused proteomics in post-mortem human spinal cord.

J. Bergquist, S. Aquilonius, Jörg Hanrieder, 2006, Journal of proteome research.

Manganese-Induced Parkinsonism due to Ephedrone Abuse

S. Aquilonius, P. Taba, S. Haldre, 2011, Parkinson's disease.

Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism.

B. Winblad, A. Carlsson, S. Aquilonius, 1980, Advances in biochemical psychopharmacology.

The increased utilisation of dopamine agonists and the introduction of COMT inhibitors have not reduced levodopa consumption--a nation-wide perspective in Sweden.

S. Aquilonius, H. Askmark, K. Antonov, 2003, Parkinsonism & related disorders.

Clinical Pharmacokinetics of Cholinesterase Inhibitors

P. Hartvig, S. Aquilonius, 1986, Clinical pharmacokinetics.

Cerebral Computed Tomography in Methanol Intoxication

Y. Olsson, S. Aquilonius, P. Enoksson, 1980, Journal of computer assisted tomography.

Large-section cryomicrotomy for in vitro receptor autoradiography.

S. Aquilonius, H. Askmark, P. Gillberg, 1986, Journal of pharmacological methods.

Levodopa‐induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET

B. Långström, P. Hartvig, S. Aquilonius, 1996, Neurology.

A pharmacokinetic study of neostigmine in man using gas chromatography-mass spectrometry

P. Hartvig, S. Aquilonius, P. O. Osterman, 1979, European Journal of Clinical Pharmacology.

Turnover of monoamine oxidase B (MAO-B) in pig brain by positron emission tomography using 11C-L-deprenyl.

B. Långström, P. Hartvig, S. Aquilonius, 1990, Journal of neural transmission. Supplementum.

Monoamine oxidase-B in motor cortex and spinal cord in amyotrophic lateral sclerosis studied by quantitative autoradiography.

S. Aquilonius, L. Oreland, J. Ekblom, 1994, Journal of neural transmission. Supplementum.

The Use of Physostigmine as an Antidote in Tricyclic Anti‐depressant Intoxication

S. Aquilonius, U. Hedstrand, 1978, Acta anaesthesiologica Scandinavica.

Stalevo reduction in dyskinesia evaluation in Parkinson's disease results were expected from a pharmacokinetic viewpoint

D. Nyholm, S. Aquilonius, H. Askmark, 2011, Annals of neurology.

Differential Increases in Catecholamine Metabolizing Enzymes in Amyotrophic Lateral Sclerosis

S. Aquilonius, J. Ekblom, S. S. Jossan, 1993, Experimental Neurology.

Central Dopaminergic Mechanisms in Monkey and Man Studied by Positron Emission Tomography

B. Långström, K. Leenders, P. Hartvig, 1987 .

The effect of L-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man.

H. Lennernäs, O. Ahrenstedt, S. Aquilonius, 1993, British journal of clinical pharmacology.

Treatment of focal hyperhidrosis with botulinum toxin type A. Brief overview of methodology and 2 years' experience

S. Aquilonius, C. Swartling, H. Naver, 1999 .

Functional positron emission tomographic studies of striatal dopaminergic activity. Changes induced by drugs and nigrostriatal degeneration.

B. Långström, P. Hartvig, S. Aquilonius, 1996, Advances in neurology.

The treatment of focal hyperhidrosis with botulinum toxin

S. Aquilonius, H. Naver, 1997 .

Palmar and axillary hyperhidrosis treated with botulinum toxin: one‐year clinical follow‐up

S. Aquilonius, C. Swartling, H. Naver, 2000, European journal of neurology.

Konzo: a distinct disease entity with selective upper motor neuron damage.

E. Stålberg, S. Aquilonius, H. Larsen, 1993, Journal of neurology, neurosurgery, and psychiatry.

Biogenic Amines and Related Enzymes in Normal Aging, Senile Dementia and Chronic Alcoholism

B. Winblad, A. Carlsson, A. Nordberg, 1981 .

Pharmacokinetics and oral bioavailability of pyridostigmine in man

P. Hartvig, S. Aquilonius, P. O. Osterman, 1980, European Journal of Clinical Pharmacology.

Pharmacokinetics of Neostigmine and Pyridostigmine in Man and Its Correlation to Clinical Effects in Myasthenia Gravis

P. Hartvig, S. Aquilonius, P. O. Osterman, 1981 .

Clinical pharmacokinetics of acetylcholinesterase inhibitors.

P. Hartvig, L. Wiklund, S. Aquilonius, 1990, Progress in brain research.

Clinical pharmacology of pyridostigmine and neostigmine in patients with myasthenia gravis.

P. Hartvig, S. Aquilonius, P. O. Osterman, 1983, Journal of neurology, neurosurgery, and psychiatry.

Manganese induced brain lesions inMacaca fascicularis as revealed by positron emission tomography and magnetic resonance imaging

B. Långström, P. Hartvig, K. Thuomas, 2005, Archives of Toxicology.

Increased Red Blood Cell Polyamines in ALS and Parkinson's Disease

S. Aquilonius, H. Askmark, I. Nygren, 2002, Experimental Neurology.

Clinical, neuroimaging and neurophysiological features in addicts with manganese‐ephedrone exposure

L. Thurfjell, R. Flink, D. Nyholm, 2010, Acta neurologica Scandinavica.

Clinical Trials with Choline and 4-Aminopyridine in Huntington’S Chorea

S. Aquilonius, S. Eckernâs, 1981 .

Plasma Choline in Healthy Subjects and in Huntington’s Chorea Patients on High Oral Doses of Choline Chloride

S. Aquilonius, S. Eckernâs, 1978 .

Free choline in human plasma analysed by simple radio-enzymatic procedure: age distribution and effect of a meal.

S. Aquilonius, S. Eckernäs, 1977, Scandinavian journal of clinical and laboratory investigation.

Cholinergic, opioid and glycine receptor binding sites localized in human spinal cord by in vitro autoradiography Changes in amyotrophic lateral sclerosis

S. Aquilonius, P. Gillberg, Sten‐Magnus Aquilonius, 1985, Acta neurologica Scandinavica.

Cerebrospinal fluid clearance of choline and some other amines.

S. Aquilonius, B. Winbladh, 1972, Acta physiologica Scandinavica.

Proceedings of the British Pharmacological Society, British Pharmacology Section. 18-20 April 1990, Sheffield. Abstracts.

S. Aquilonius, J. Reviriego, G. Alván, 1990, British journal of clinical pharmacology.

Levodopa Pharmacokinetics and Motor Performance During Activities of Daily Living in Patients With Parkinson's Disease on Individual Drug Combinations

H. Lennernäs, D. Nyholm, S. Aquilonius, 2002, Clinical neuropharmacology.

The fate of intracerebroventribular injection of atropine and methylatropine in relation to their pharmacological effects.

S. Aquilonius, B. Winbladh, L. Albanus, 2009, Acta pharmacologica et toxicologica.

Chapter 37 Spinal cholinergic mechanisms

S. Aquilonius, H. Askmark, P. Gillberg, 1990 .

Muscarinic binding sites in small homogenates and in autoradiographic sections from rat and human spinal cord

A. Nordberg, S. Aquilonius, P. Gillberg, 1984, Brain Research.

[Survey of the prescription of anti-parkinson drugs in Sweden during the seventies].

P. Hartvig, S. Aquilonius, 1980, Lakartidningen.

Acetylcholine synthesizing activity and nicotinic binding sites in rat hind limb muscles during reinnervation.

A. Nordberg, S. Aquilonius, H. Askmark, 1982, Acta physiologica Scandinavica.

Effect of denervation on acetylcholine synthesizing activity and nicotine-like binding sites in rat hind limb muscles.

A. Nordberg, S. Aquilonius, H. Askmark, 1982, Acta physiologica Scandinavica.

Cholinergic Mechanisms in Spinal Cord and Muscle

S. Aquilonius, H. Askmark, P. G. Gilberg, 1986 .

The Use of Physostigmine as an Antidote in Tricyclic Antidepressant Intoxication

S. Aquilonius, U. Hedstrand, 1979 .

Clinical pharmacokinetics of intravenous and oral 9-amino-1,2,3,4-tetrahydroacridine, tacrine

P. Hartvig, L. Wiklund, S. Aquilonius, 2004, European Journal of Clinical Pharmacology.

CHOLINERGIC MECHANISMS IN SPINAL CORD

S. Aquilonius, P. Gillberg, 1984 .

Levels ofl-MethionineS-Adenosyltranferase Activity in Erythrocytes and Concentrations ofS-Adenosylmethionine andS-Adenosylhomocysteine in Whole Blood of Patients with Parkinson's Disease

S. Aquilonius, L. Oreland, J. Ekblom, 1997, Experimental Neurology.

Evidence for astrocytosis in ALS demonstrated by [11C](l)-deprenyl-D2 PET

H. Engler, A. Wall, B. Långström, 2007, Journal of the Neurological Sciences.

Localization of monoamine oxidase B in human brain by autoradiographical use of11C-labelled L-deprenyl

B. Långström, C. Halldin, S. Aquilonius, 2005, Journal of Neural Transmission.

Monoamine oxidase‐B in astrocytes

S. Aquilonius, E. Walum, L. Oreland, 1993, Glia.

Quantitative localization of human brain monoamine oxidase B by large section autoradiography using l-[3H]deprenyl

C. Halldin, S. Aquilonius, L. Oreland, 1991, Brain Research.

Parkinsonism and neck extensor myopathy: a new syndrome or coincidental findings?

Y. Olsson, A. Johansson, S. Aquilonius, 2001, Archives of neurology.

Complexity of Motor Response to Different Doses of Duodenal Levodopa Infusion in Parkinson Disease

H. Lennernäs, D. Nyholm, A. Johansson, 2012, Clinical neuropharmacology.

Levodopa Infusion Therapy in Parkinson Disease: State of the Art in 2004

D. Nyholm, S. Aquilonius, 2004, Clinical neuropharmacology.

Pharmacokinetics and effects of levodopa in advanced Parkinson's disease

S. Aquilonius, L. Paalzow, S.-M. Aquilonius, 2004, European Journal of Clinical Pharmacology.

Optimizing Levodopa Pharmacokinetics: Intestinal Infusion Versus Oral Sustained-Release Tablets

H. Lennernäs, D. Nyholm, S. Aquilonius, 2003, Clinical neuropharmacology.

Enteral Levodopa/Carbidopa Infusion in Advanced Parkinson Disease: Long-term Exposure

T. Lewander, D. Nyholm, A. Johansson, 2008, Clinical neuropharmacology.

Reversible chorea in primary antiphospholipid syndrome

S. Aquilonius, J. Tedroff, J. Sunden-Cullberg, 1998, Movement disorders : official journal of the Movement Disorder Society.

A comparative study of methionine adenosyltransferase activity and regional distribution in mammalian spinal cord.

S. Aquilonius, C. Gomes-Trolin, T. Ekegren, 2000, Biochemical pharmacology.

Physiotherapy in cervical dystonia: Six experimental single-case studies

S. Aquilonius, K. Halvorsen, B. Lindmark, 2008, Physiotherapy theory and practice.

Insulin-like growth factor-1 receptors in human spinal cord: changes in amyotrophic lateral sclerosis

B. Winblad, L. Wang, S. Aquilonius, 2005, Journal of Neural Transmission / General Section JNT.

Increased binding of3H-L-deprenyI in spinal cords from patients with amyotrophic lateral sclerosis as demonstrated by autoradiography

S. Aquilonius, H. Askmark, P. Gillberg, 2005, Journal of Neural Transmission / General Section JNT.

No re-expression of high-affinity nerve growth factor binding sites in spinal motor neurons in amyotrophic lateral sclerosis.

S. Aquilonius, H. Askmark, T. Ebendal, 1992, European Neurology.

Biochemical changes in Dementia disorders of Alzheimer type (AD/SDAT)

B. Winblad, A. Nordberg, S. Aquilonius, 1983, Neurobiology of Aging.

Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography‐Fourier transform ion cyclotron resonance mass spectrometry

K. Markides, J. Bergquist, R. Zubarev, 2004, Proteomics.

Irreversible motor impairment in young addicts – ephedrone, manganism or both?

J. Bergquist, D. Nyholm, S. Aquilonius, 2007, Acta neurologica Scandinavica.

Autoradiographic distribution of [3H]acetylcholine binding sites in the cervical spinal cord of man and some other species

S. Aquilonius, P. Gillberg, R. D'argy, 1988, Neuroscience Letters.

Topographical localization of choline acetyltransferase within the human spinal cord and a comparison with some other species

S. Aquilonius, P. Gillberg, S. Eckernäs, 1981, Brain Research.

Cholinergic and dopaminergic mechanisms in Huntington's chorea.

S. Aquilonius, R. Sjöström, 1971, Life sciences. Pt. 1: Physiology and pharmacology.

Levels of L-methionine S-adenosyltransferase activity in erythrocytes and concentrations of S-adenosylmethionine and S-adenosylhomocysteine in whole blood of patients with Parkinson's disease.

S. Aquilonius, L. Oreland, J. Ekblom, 1997, Experimental neurology.

The Use of Positron Emission Tomography for the Evaluation of Choline Metabolism in the Brain of the Rhesus Monkey

B. Långström, K. Någren, K. Bergström, 1986 .

In vivo and in vitro receptor autoradiography of the human brain using an 11C-labelled benzodiazepine analogue

B. Långström, M. Bergström, B. Långström, 1988, Neuroscience Letters.

Long‐term intraduodenal infusion of a water based levodopa‐carbidopa dispersion in very advanced Parkinson's disease

L. Hansson, S. Aquilonius, L. Paalzow, 1998, Acta neurologica Scandinavica.

Studies on phosphorylated thiocholine and choline derivatives

S. Aquilonius, A. Sundwall, T. Fredriksson, 1964 .

A simple radioenzymatic procedure for the determination of choline and acetylcholine in brain regions of rats sacrificed by microwave irradiation.

S. Aquilonius, S. Eckernäs, 1977, Acta physiologica Scandinavica.

The arteriovenous difference of choline across the brain of man

S. Aquilonius, J. Schuberth, H. Malmlund, 1975, Brain Research.

In vivo studies of two choline acetyltransferase inhibitors.

S. Aquilonius, B. Winbladh, L. Frankenberg, 2009, Acta pharmacologica et toxicologica.

Choline acetyltransferase in human cerebrospinal fluid: non‐enzymatically and enzymatically catalysed acetylcholine synthesis

S. Aquilonius, S. Eckernäs, 1976, Journal of neurochemistry.

In vivo evaluation of striatal dopamine reuptake sites using 11C‐nomifensine and positron emission tomography

B. Långström, G. Antoni, B. Långström, 1987, Acta neurologica Scandinavica.

Receptor alterations in manganese intoxicated monkeys

S. Aquilonius, P. Gillberg, H. Eriksson, 2005, Archives of Toxicology.

Aspects of Cholinergic Function in Amyotrophic Lateral Sclerosis

S. Aquilonius, P. Gillberg, 1987 .

Circadian Rhythmicity in Levodopa Pharmacokinetics in Patients With Parkinson Disease

H. Lennernäs, D. Nyholm, A. Johansson, 2010, Clinical neuropharmacology.

Objective assessment of cervical dystonia: a pilot study

E. Lundström, S. Aquilonius, K. Halvorsen, 2005, Acta neurologica Scandinavica.

Gender differences in Parkinson's disease symptom profile

H. Engler, S. Aquilonius, B. Scott, 2000, Acta neurologica Scandinavica.

Duodenal levodopa infusion in Parkinson's disease – long‐term experience

D. Nyholm, S. Aquilonius, D. Nilsson, 2001, Acta neurologica Scandinavica.

Neurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markers

B. Långström, P. Hartvig, K. Thuomas, 1995, Movement disorders : official journal of the Movement Disorder Society.

Unilateral MPTP lesion in a rhesus monkey: effects on the striatal dopaminergic system measured in vivo with PET using various novel tracers

K. L. Leenders, B. Långström, B. Långström, 1988, Brain Research.

Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C‐N‐methyl‐spiperone

P. Hartvig, S. Aquilonius, S. Eckernäs, 1987, Acta neurologica Scandinavica.

Choline acetyltransferase activity in human blood and its diurnal oscillation--an artifact?

S. Aquilonius, O. Mäepea, S. Eckernäs, 1979, Medical biology.

Cerebral uptake and utilization of therapeutic [β‐11C]‐L‐DOPA in Parkinson's disease measured by positron emission tomography. Relations to motor response

B. Långström, P. Hartvig, S. Aquilonius, 1992, Acta neurologica Scandinavica.

Manganese‐induced parkinsonism in methcathinone abusers: bio‐markers of exposure and follow‐up

S. Aquilonius, P. Taba, S. Haldre, 2013, European journal of neurology.

Impact of dystonia on quality of life and health in a Swedish population

S. Aquilonius, B. Lindmark, L. Zetterberg, 2009, Acta neurologica Scandinavica.

Parkinson's disease--etiology and smoking.

S. Aquilonius, 1989, Progress in brain research.

PHYSOSTIGMINE IN THE TREATMENT OF DRUG OVERDOSE

S. Aquilonius, 1978 .

Peripheral Blood RNA Expression Profiling in Illicit Methcathinone Users Reveals Effect on Immune System

L. Schalkwyk, S. Kõks, S. Aquilonius, 2011, Front. Gene..

Cortical and striatal in vivo uptake and metabolism of plasma choline in the rat: effects of haloperidol and apomorphine.

S. Aquilonius, S. Eckernäs, 2009, Acta pharmacologica et toxicologica.

[Hyperhidrosis--the "silent" handicap].

S. Aquilonius, K. Brismar, C. Swartling, 2011, Läkartidningen.

Striatal kinetics of [11C]‐(+)‐nomifensine and 6‐[18F]fluoro‐L‐dopa in Parkinson's disease measured with positron emission tomography

G. Antoni, B. Långström, P. Hartvig, 1990, Acta neurologica Scandinavica.

A multiple motion sensors index for motor state quantification in Parkinson's disease

Alexander Medvedev, Jerker Westin, Dag Nyholm, 2020, Comput. Methods Programs Biomed..

Intraduodenal infusion of a water-based levodopa dispersion for optimisation of the therapeutic effect in severe Parkinson's disease

S. Aquilonius, L. Paalzow, E. Bredberg, 2004, European Journal of Clinical Pharmacology.

Absorption of L-DOPA from the proximal small intestine studied in the rhesus monkey by positron emission tomography.

B. Långström, P. Hartvig, H. Lennernäs, 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Relationship between drug-induced changes in blood pressure and cerebral oxygen availability.

S. Aquilonius, B. Winbladh, A. Sundwall, 1968, Acta physiologica Scandinavica.

Clinical Pharmacokinetics of Centrally Acting Cholinesterase Inhibitors

P. Hartvig, L. Wiklund, S. Aquilonius, 1991 .

Functional and pharmacokinetic studies of tetrahydroaminoacridine in patients with amyotrophic lateral sclerosis

P. Hartvig, E. Stålberg, S. Aquilonius, 1990, Acta Neurologica Scandinavica.

Upregulation of Bax protein and increased DNA degradation in ALS spinal cord motor neurons

S. Aquilonius, D. Lindholm, E. Grundström, 1999, Acta neurologica Scandinavica.

Regional kinetics of [11C]methylspiperone in the brain studied by positron emission tomography in patients with Parkinson's disease.

B. Långström, K. Någren, K. Bergström, 1987, Advances in neurology.

Monoamine oxidase-B in motor cortex: Changes in amyotrophic lateral sclerosis

S. Aquilonius, L. Oreland, P. Gillberg, 1992, Neuroscience.

Large section cryomicrotomy: a basic method for microdissectioning and in vitro autoradiography of human nervous tissue.

S. Aquilonius, 1986, Upsala journal of medical sciences.

Topographical localization of end-plates in cryosections of whole human biceps muscle.

S. Aquilonius, H. Askmark, P. Gillberg, 1982, Muscle & nerve.

[Injection of botulinum toxin as a new treatment of torticollis].

S. Aquilonius, K. Cesarini, E. Stålberg, 1990, Lakartidningen.

SYNTHESIS OF ACETYLCHOLINE IN DIFFERENT COMPARTMENTS OF BRAIN NERVE TERMINALS IN VIVO AS STUDIED BY THE INCORPORATION OF CHOLINE FROM PLASMA AND THE EFFECT OF PENTOBARBITAL ON THIS PROCESS

S. Aquilonius, J. Schuberth, F. Flentge, 1973, Journal of neurochemistry.

Effects of some anticholinergic drugs on cortical acetylcholine release and motor activity in rats.

S. Aquilonius, B. Winbladh, B. Lundholm, 1972, European journal of pharmacology.

Effects of atropine treatment on cortical, striatal and hippocampal high-affinity uptake of choline in the mouse.

S. Aquilonius, S. Eckernäs, L. Sahlström, 1980, Life sciences.

Utilization of antiparkinson drugs in Norway, Sweden, Denmark and Finland 1975–1979

P. Hartvig, S. Aquilonius, Marianne Granat, 1981, Acta neurologica Scandinavica.

Parkinson's disease after open‐heart surgery

S. Aquilonius, Jarl V. Hägglund, 1996, Movement disorders : official journal of the Movement Disorder Society.

Focal dystonia secondary to superficial siderosis

S. Aquilonius, Jarl Hagglund, 1996, Movement disorders : official journal of the Movement Disorder Society.

Cytotoxic effects of ALS serum on human cell lines

S. Aquilonius, E. Walum, J. Ekblom, 1995, Journal of the Neurological Sciences.